Figure 2 A model of TNFR–complex I signalling

Slides:



Advertisements
Similar presentations
Tyrosine kinase signalling (review) TGF signalling Notch signalling.
Advertisements

TNF superfamily TNF: produced by macrophages, monocytes, lymphocytes, fibroblasts upon inflammation, infection, injury, environmental challenges.
Linear ubiquitination: A novel NF-κB regulatory mechanism for inflammatory and immune responses by the LUBAC ubiquitin ligase complex 陈洁
Receptor-Ligand Interactions.. k 1 R + L  RL K -1 [RL] Ka = _____ [R] [L] Affinity constant (M -1 ) [R] [L] Kd = ______ [RL] Dissociation constant.
Date of download: 6/21/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Cellular signaling pathways for production ofinflammatory cytokines.
Date of download: 7/8/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Cellular signaling pathways for production of inflammatory cytokines.
Cellular signaling pathways for production of inflammatory cytokines in response to microbial products. Microbial cell-surface constituents interact with.
Figure 1 Simplified scheme of TGFβ signalling
Figure 2 Inflammatory pathways affecting hepatic insulin resistance
Cellular and Molecular Mechanisms of Liver Injury
Figure 2 Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis Figure 2 | Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis.
Smac Mimetics and TNFα: A Dangerous Liaison?
Figure 4 Simplified T cell and antigen presenting
D.H. Dockrell  Clinical Microbiology and Infection 
Cellular and Molecular Mechanisms of Liver Injury
Figure 5 Defects in the JAK–STAT signalling pathway
Innate signals in mucosal immunoglobulin class switching
Nat. Rev. Endocrinol. doi: /nrendo
Toll-like receptors: Applications to dermatologic disease
NOD-like and Toll-like receptors or inflammasomes contribute to kidney disease in a canonical and a non-canonical manner  Hans-Joachim Anders, Maciej.
Fas NF-κB JNK Bcl-2 Akt p21 Bax Ras TRAILR p53 EGFR TRADD Myc TNFR
Figure 7 Defects in apoptosis
Toll-like receptors in Borrelia burgdorferi-induced inflammation
Figure 3 Molecular mechanisms of crystal-induced necroinflammation
Whipping NF-κB to Submission via GADD45 and MKK7
Tumor necrosis factor: Biology and therapeutic inhibitors
Figure 2 Oestrogen receptor signalling pathways
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Keratins and the Keratinocyte Activation Cycle
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Transcriptional inflammatory response to hypoxia and cellular necrosis
Pathogen Recognition and Innate Immunity
The Two Faces of Receptor Interacting Protein Kinase-1
A Liver Full of JNK: Signaling in Regulation of Cell Function and Disease Pathogenesis, and Clinical Approaches  Ekihiro Seki, David A. Brenner, Michael.
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Immune defects caused by mutations in the ubiquitin system
Connecting Mitochondria and Innate Immunity
Cell Communication (Signaling) Part 3
Mitochondrial Signaling
Experimental Hematology
Signal transduction by TNF-α leads to apoptosis or necroptosis.
Death receptor-mediated apoptosis and the liver
Roles of Caspases in Necrotic Cell Death
The Met1-Linked Ubiquitin Machinery: Emerging Themes of (De)regulation
Nat. Rev. Rheumatol. doi: /nrrheum
Functional Diversity and Regulation of Different Interleukin-1 Receptor-Associated Kinase (IRAK) Family Members  Sophie Janssens, Rudi Beyaert  Molecular.
Toll-like receptors Current Biology
Intracellular Toll-like Receptors
Manfred Fliegauf, PhD, Bodo Grimbacher, MD 
Volume 19, Issue 5, Pages (September 2005)
NF-κB activation in pathogenesis and therapy of cancer.
Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart
Antigen-Receptor Signaling to Nuclear Factor κB
Cell Communication (Signaling) Part 3
RelA Life and Death Decisions
A possible mechanism of renal cell death after ischemia/reperfusion
Alterations to TNFR1 signaling and complex formation in the absence of TRADD. (A–C) ERK, JNK, and IκB. traddWT/WT and traddKO/KO MEFs (A) and BM-Macs (B)
Immunoregulatory role of TNFα in inflammatory kidney diseases
Components and outcomes of selected TNF-superfamily signalling pathways. Components and outcomes of selected TNF-superfamily signalling pathways. (Left)
The TNF Receptor 1 Cell Volume 114, Issue 2, Pages (July 2003)
Functional Diversity and Regulation of Different Interleukin-1 Receptor-Associated Kinase (IRAK) Family Members  Sophie Janssens, Rudi Beyaert  Molecular.
Sam68 Guest STARs in TNF-α Signaling
Macrophages, Immunity, and Metabolic Disease
Tumor necrosis factor: Biology and therapeutic inhibitors
NF-κB, Inflammation, and Metabolic Disease
Different signaling pathways of TLR2, Nod, and TNFR1 in response to ligand, resulting in activation of NF-κB, the nuclear transcriptional factor responsible.
Toll-like receptors, adapter proteins, and signaling molecules.
Presentation transcript:

Figure 2 A model of TNFR–complex I signalling Figure 2 | A model of TNFR–complex I signalling. The binding of homotrimeric TNF to homotrimeric TNF receptors (TNFRs) induces the formation of complex I, comprising TNFR1-associated death domain protein (TRADD), receptor-interacting serine/threonine-protein kinase 1 (RIPK1), TNFR-associated factor 2 (TRAF2), cellular inhibitor of apoptosis protein 1 (cIAP1) or cIAP2, and linear ubiquitin chain assembly complex (LUBAC). cIAPs and LUBAC decorate RIPK1 with scaffolding Lys63-linked and Met1-linked polyubiquitin chains, inducing the recruitment of transforming growth factor (TGF)-β-activated kinase 1 (TAK1) and inhibitor of κB (IκB) kinase (IKK) complexes. TAK1 activates p38 and JUN N-terminal kinase (JNK), leading to the transcription of AP1-target genes. IKKβ phosphorylates IκB, inducing its proteasomal degradation and the release of nuclear factor κB (NFκB). Free NFκB translocates to the nucleus, where it induces the expression of target genes. NEMO, NFκB essential modulator; TAB, TAK1-binding protein. Kalliolias, G. D. & Ivashkiv, L. B. (2015) TNF biology, pathogenic mechanisms and emerging therapeutic strategies Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2015.169